Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: An open label prospective study

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Ngasala, Billy E ^a,b   Malmberg, Maja ^a   Carlsson, Anja M ^a   Ferreira, Pedro E ^a,g   Petzold, Max G ^c,d   Blessborn, Daniel ^e,f   Bergqvist, Yngve ^e,f   Gil, José P ^a,g,h   Premji, Zul ^b   Mårtensson, Andreas ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c KAROLINSKA INSTITUTE   (Sweden)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^e DALARNA UNIVERSITY   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY OF ALGARVE   (Portugal)

^h BINGHAMTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; PROTOZOAL DNA;

ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE TRANSMISSION; FEMALE; FEVER; HEALTH AUXILIARY; HUMAN; INFANT; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; OPEN STUDY; OUTCOME ASSESSMENT; PARASITEMIA; PARENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECURRENT INFECTION; RURAL AREA; SURVIVAL; TANZANIA; BLOOD; CLINICAL TRIAL; DRUG COMBINATION; METHODOLOGY; PARASITOLOGY; RURAL POPULATION; TREATMENT OUTCOME;

ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DNA, PROTOZOAN; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PARASITOLOGY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RURAL POPULATION; TANZANIA; TREATMENT OUTCOME;

EID: 79952699460     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-64     Document Type: Article

References (51)

1. WHO/HTM/GMP/2008.1. World Health Organization, World Malaria Report 2008 http://www.who.int/malaria/wmr2008/malaria2008.pdf
2. WHO/HTM/MAL/2005.1101. World Health Organization, The roll back malaria strategy for improving access to treatment through home management of malaria http://www.who.int/malaria/publications/atoz/who-htm-mal-2005-1101/en/index.html
3. Roll Back Malaria Partnership, The Global Malaria Action Plan 2008 http://rbm.who.int/gmap/gmap.pdf
4. The Millennium Development Goals Report 2008. http://mdgs.un.org/unsd/ mdg/Resources/Static/Products/Progress2008/MDG-Report-2008-En.pdf
5. World Health Organization/Special Programme for Research and Training in Tropical Diseases, WHO/HTM/MAL/2004.1096; TDR/IDE/HMM/04.1. WHO, Scaling-up Home-based Management of Malaria.From Research to Implementation http://whqlibdoc.who.int/hq/2004/WHO-HTM-MAL-2004.1096.pdf
6. A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. F Pagnoni N Convelbo J Tiendrebeogo S Cousens F Esposito, Trans R Soc Trop Med Hyg 1997 91 512 517 (Pubitemid 27478632)
7. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. SB Sirima A Konate AB Tiono N Convelbo S Cousens F Pagnoni, Trop Med Int Health 2003 8 133 139 (Pubitemid 36269364)
8. Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. G Kidane RH Morrow, Lancet 2000 356 550 555 (Pubitemid 30611860)
9. WHO, Guidelines for the treatment of malaria, second edition http://www.who.int/malaria/publications/atoz/9789241547925/en/index.html
10. Global AMDP database - WHO African region. http://www.who.int/malaria/am- drug-policies-by-region-afro/en/
11. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. P Piola C Fogg F Bajunirwe S Biraro F Grandesso E Ruzagira J Babigumira I Kigozi J Kiguli J Kyomuhendo L Ferradini W Taylor F Checchi JP Guthmann, Lancet 2005 365 1467 1473 (Pubitemid 40591691)
12. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. TK Mutabingwa D Anthony A Heller R Hallett J Ahmed C Drakeley BM Greenwood CJ Whitty, Lancet 2005 365 1474 1480 (Pubitemid 40591692)
13. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. JF Faucher A Aubouy A Adeothy G Cottrell J Doritchamou B Gourmel P Houze H Kossou H Amedome A Massougbodji M Cot P Deloron, J Infect Dis 2009 200 57 65
14. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. J Achan JK Tibenderana D Kyabayinze F Wabwire Mangen MR Kamya G Dorsey U D'Alessandro PJ Rosenthal AO Talisuna, BMJ 2009 339 2763
15. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. IO Ajayi EN Browne B Garshong F Bateganya B Yusuf P Agyei-Baffour L Doamekpor A Balyeku K Munguti S Cousens F Pagnoni, Malar J 2008 7 6
16. Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. AM Chinbuah JO Gyapong F Pagnoni EK Wellington M Gyapong, Trop Med Int Health 2006 11 1003 1016 (Pubitemid 44015239)
17. malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania. M Mubi A Janson M Warsame A Mårtensson K Källander MG Petzold B Ngasala G Maganga LL Gustafsson A Massele G Tomson Z Premji A Björkman, PLoS One 2011
18. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. H Hopkins A Talisuna CJ Whitty SG Staedke, Malar J 2007 6 134
19. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. IO Ajayi EN Browne F Bateganya D Yar C Happi CO Falade GO Gbotosho B Yusuf S Boateng K Mugittu S Cousens M Nanyunja F Pagnoni, Malar J 2008 7 190
20. History, dynamics, and public health importance of malaria parasite resistance. AO Talisuna P Bloland U D'Alessandro, Clin Microbiol Rev 2004 17 235 254 (Pubitemid 38120936)
21. Laboratory diagnosis of malaria by village health workers using the rapid manual ParaSight-F test. Z Premji JN Minjas CJ Shiff, Trans R Soc Trop Med Hyg 1994 88 418
22. Performance appraisal of rapid on-site malaria diagnosis (ICT malaria Pf/Pv test) in relation to human resources at village level in Myanmar. N Cho Min ML Gatton, Acta Trop 2002 81 13 19 (Pubitemid 34033709)
23. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. KI Barnes P Chanda G Ab Barnabas, Malar J 2009 8 Suppl 1 8
24. National guidelines for malaria diagnosis and treatment. NMCP Tanzania (ed), Dar es Salaam 2006
25. Genotyping of Plasmodium spp. Nested PCR. G Snounou, Methods Mol Med 2002 72 103 116
26. Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. MI Veiga PE Ferreira A Bjorkman JP Gil, Mol Cell Probes 2006 20 100 104 (Pubitemid 43343722)
27. Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. D Blessborn S Romsing A Annerberg D Sundquist A Bjorkman N Lindegardh Y Bergqvist, J Pharm Biomed Anal 2007 45 282 287
28. WHO/HTM/RBM/2003.50. WHO, Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria http://www.who.int/malaria/publications/atoz/whohtmrbm200350/en/
29. Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. BE Ngasala M Malmberg AM Carlsson PE Ferreira MG Petzold D Blessborn Y Bergqvist JP Gil Z Premji A Bjorkman A Martensson, Clin Infect Dis 2011
30. ClinicalTrial.gov. http://www.ClinicalTrials.gov
31. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. F Ezzet R Mull J Karbwang, Br J Clin Pharmacol 1998 46 553 561 (Pubitemid 28522119)
32. How antimalarial drug resistance affects post-treatment prophylaxis. NJ White, Malar J 2008 7 9
33. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. H Bukirwa A Yeka MR Kamya A Talisuna K Banek N Bakyaita JB Rwakimari PJ Rosenthal F Wabwire-Mangen G Dorsey SG Staedke, PLoS Clin Trials 2006 1 7
34. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. MR Kamya A Yeka H Bukirwa M Lugemwa JB Rwakimari SG Staedke AO Talisuna B Greenhouse F Nosten PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Clin Trials 2007 2 20
35. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. I Zongo G Dorsey N Rouamba C Dokomajilar Y Sere PJ Rosenthal JB Ouedraogo, Clin Infect Dis 2007 45 1453 1461 (Pubitemid 351411875)
36. Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. A Martensson B Ngasala J Ursing M Isabel Veiga L Wiklund C Membi SM Montgomery Z Premji A Farnert A Bjorkman, J Infect Dis 2007 195 597 601 (Pubitemid 46214404)
37. World Malaria Report 2008. WHO, WHO/HTM/GMP/2008.1 World Health Organization http://www.who.int/malaria/wmr2008/malaria2008.pdf
38. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. DJ Bell D Wootton M Mukaka J Montgomery N Kayange P Chimpeni DA Hughes ME Molyneux SA Ward PA Winstanley DG Lalloo, Malar J 2009 8 204
39. Case management of malaria in under-fives at primary health care facilities in a Tanzanian district. SE Nsimba AY Massele J Eriksen LL Gustafsson G Tomson M Warsame, Trop Med Int Health 2002 7 201 209 (Pubitemid 34264372)
40. Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda. F Checchi P Piola C Fogg F Bajunirwe S Biraro F Grandesso E Ruzagira J Babigumira I Kigozi J Kiguli J Kyomuhendo L Ferradini WR Taylor JP Guthmann, Malar J 2006 5 59
41. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. NJ White M van Vugt F Ezzet, Clin Pharmacokinet 1999 37 105 125
42. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. NJ White M van Vugt F Ezzet, Clin Pharmacokinet 1999 37 105 125
43. The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. S Borrmann WM Sallas S Machevo R Gonzalez A Bjorkman A Martensson M Hamel E Juma J Peshu B Ogutu A Djimde U D'Alessandro AC Marrast G Lefevre SE Kern, Trop Med Int Health 2010 15 434 441
44. The evolution of drug-resistant malaria: the role of drug elimination half-life. IM Hastings WM Watkins NJ White, Philos Trans R Soc Lond B Biol Sci 2002 357 505 519 (Pubitemid 34489862)
45. Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. AM Nzila E Nduati EK Mberu C Hopkins Sibley SA Monks PA Winstanley WM Watkins, J Infect Dis 2000 181 2023 2028 (Pubitemid 30416167)
46. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. C Sisowath I Petersen MI Veiga A Martensson Z Premji A Bjorkman DA Fidock JP Gil, J Infect Dis 2009 199 750 757
47. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 1014 1017 (Pubitemid 40349821)
48. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. C Dokomajilar SL Nsobya B Greenhouse PJ Rosenthal G Dorsey, Antimicrob Agents Chemother 2006 50 1893 1895
49. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. GS Humphreys I Merinopoulos J Ahmed CJ Whitty TK Mutabingwa CJ Sutherland RL Hallett, Antimicrob Agents Chemother 2007 51 991 997 (Pubitemid 46355285)
50. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. CT Happi GO Gbotosho OA Folarin A Sowunmi T Hudson M O'Neil W Milhous DF Wirth AM Oduola, Antimicrob Agents Chemother 2009 53 888 895
51. In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. L Mwai SM Kiara A Abdirahman L Pole A Rippert A Diriye P Bull K Marsh S Borrmann A Nzila, Antimicrob Agents Chemother 2009 53 5069 5073